OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis
Yongjun Sun, Jie Ma, Jun-Kai Lin, et al.
Anti-Cancer Drugs (2021) Vol. 32, Iss. 9, pp. 950-961
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

CircRNA: A new class of targets for gastric cancer drug resistance therapy
Ying Zheng, Zhe Li, Yao Wang, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 19

Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies
Chou‐Yi Hsu, Ahmed Faisal, Sally Salih Jumaa, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 970-994
Open Access | Times Cited: 6

Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p/TRIM14/Dvl2/Wnt/β-catenin axis
Yuan Chen, Haofeng Liu, Junwei Zou, et al.
Human Cell (2022) Vol. 36, Iss. 1, pp. 258-275
Closed Access | Times Cited: 26

The Role of Circular RNAs in the Drug Resistance of Cancers
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 25

circ_0006089 promotes gastric cancer growth, metastasis, glycolysis, and angiogenesis by regulating miR‐361‐3p/TGFB1
Ying Zhou, Qilin Zhang, Bingling Liao, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 2044-2055
Open Access | Times Cited: 23

A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115337-115337
Open Access | Times Cited: 15

Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target
Abdollah Jafarzadeh, Mohammad Hossein Paknahad, Maryam Nemati, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112600-112600
Open Access | Times Cited: 32

The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 19

Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer
Dai Cheng, Shiyuan Dai, Yan Gao, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11

Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access

Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2/SLC7A11 by miR-770-5p
Qin Li, Xiangjian Meng, Qiang Hua
Acta Diabetologica (2022) Vol. 60, Iss. 1, pp. 29-42
Closed Access | Times Cited: 16

Circular RNA circ_0006089 promotes the progression of gastric cancer by regulating the miR‐143‐3p/PTBP3 axis and PI3K/AKT signaling pathway
Guang Rong Lin, Wei Rong Chen, Pei Hong Zheng, et al.
Journal of Digestive Diseases (2022) Vol. 23, Iss. 7, pp. 376-387
Closed Access | Times Cited: 11

Advances in the Study of CircRNAs in Tumor Drug Resistance
Song Wang, Long Qian, Tingting Cao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10

Sinomenine regulates circTRPM7‐related pathway to inhibit gastric cancer cell growth and metastasis
Jingwei Yan, Jingqing Yang, Huifen Shen, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 870-881
Open Access | Times Cited: 4

Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance
Noriaki Sunaga, Yosuke Miura, Tomomi Masuda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 710-710
Open Access | Times Cited: 1

Circular RNAs as biomarkers and therapeutic targets for gastrointestinal cancers
Godwin Botwe, Xinjian Fang, Yusif Mohammed Mukhtar, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1230-1246
Open Access | Times Cited: 1

Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy
Ling Lu, Zihan Gao, Longtao Jin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

circ_0006089 facilitates gastric cancer progression and oxaliplatin resistance via miR-217/NRP1
Ying Zhou, Qilin Zhang, Qihua Xu, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155596-155596
Closed Access | Times Cited: 1

CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression
Yuluo Wu, Haiyang Zhao
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 9

The critical role of circular RNAs in drug resistance in gastrointestinal cancers
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, et al.
Medical Oncology (2023) Vol. 40, Iss. 4
Closed Access | Times Cited: 3

Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation
Yukitomo Ishi, Shigeru Yamaguchi, Michinari Okamoto, et al.
Brain Tumor Pathology (2022) Vol. 39, Iss. 3, pp. 162-170
Closed Access | Times Cited: 5

Functional properties of circular RNAs and research progress in gastric cancer
Pingan Ding, Pengpeng Liu, Haotian Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3

Identification and validation of autophagy‑related genes in hypertrophic cardiomyopathy.
Rongbin Qiu, Shi-Tao Zhao, Zhiwei Li, et al.
PubMed (2024) Vol. 28, Iss. 6, pp. 440-440
Closed Access

Page 1 - Next Page

Scroll to top